title: Transport kinetics of pseudouridine during hemodialysis and continuous ambulatory peritoneal dialysis.
abstract: It has been found that the concentrations of pseudouridine in serum of patients undergoing continuous ambulatory peritoneal dialysis (CAPD) are higher than those in patients undergoing hemodialysis. We analyzed whether this could be caused by a lower rate of transport in CAPD when compared with hemodialysis. Mass transfer area coefficients (MTCs) for urea, creatinine, uric acid, and pseudouridine were determined in nine patients undergoing hemodialysis as dialyzer clearances and in 14 patients undergoing CAPD during a 4-hour dwell with 2 L dialysate with glucose, 70 mmol/L. The theoretical MTC of pseudouridine (TPSI), calculated by extrapolation to its molecular weight by use of the MTC of urea, creatinine, and uric acid, was higher than the observed MTC of pseudouridine, both in hemodialysis (136 vs 112 ml/min, p less than 0.025) and in CAPD (6.9 vs 3.4 ml/min, p less than 0.001). The pseudouridine/TPSI MTC ratio was lower during CAPD than during hemodialysis (0.47 vs 0.83, p less than 0.0005), indicating a lower level of transport during CAPD. In vitro experiments with nuclear magnetic resonance spectroscopy supported the hypothesis of glucose-induced molecular association of pseudouridine. Therefore, dialysate containing 10 mmol/L glucose was compared with that containing 70 mmol/L glucose in eight patients undergoing CAPD. The MTC of pseudouridine was higher during the experiments with dialysate containing 10 mmol/L glucose (3.5 +/- 2.0 ml/min vs 2.7 +/- 1.9 ml/min, p less than 0.05). This was also found for the pseudouridine/TPSI MTC ratio (0.61 vs 0.41, p less than 0.02) and the pseudouridine/creatinine MTC ratio (0.33 vs 0.25, p less than 0.02), favoring glucose-induced decrease of MTC-pseudouridine.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Medicine, Academic Medical Center, University of Amsterdam, The Netherlands.
authors.forename: D G
authors.initials: DG
authors.lastname: Struijk
authors.forename: A C
authors.initials: AC
authors.lastname: Schoots
authors.forename: L H
authors.initials: LH
authors.lastname: Koole
authors.forename: H J
authors.initials: HJ
authors.lastname: van der Reijden
authors.forename: G C
authors.initials: GC
authors.lastname: Koomen
authors.forename: R T
authors.initials: RT
authors.lastname: Krediet
authors.forename: L
authors.initials: L
authors.lastname: Arisz
mesh_terms: D001692:Biological Transport; D015314:Dialysis Solutions; D005947:Glucose / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D009682:Magnetic Resonance Spectroscopy; D015394:Molecular Structure; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011560:Pseudouridine / Q000097:blood / Q000737:chemistry / Q000378:metabolism*; D006435:Renal Dialysis
chemical_list: D015314:Dialysis Solutions; D011560:Pseudouridine; D005947:Glucose